Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study
- Author:
Hayoung CHOI
1
;
Hyun LEE
;
Seung Won RA
;
Jong Geol JANG
;
Ji-Ho LEE
;
Byung Woo JHUN
;
Hye Yun PARK
;
Ji Ye JUNG
;
Seung Jun LEE
;
Kyung-Wook JO
;
Chin Kook RHEE
;
Changwhan KIM
;
Sei Won LEE
;
Kyung Hoon MIN
;
Yong-Soo KWON
;
Deog Kyeom KIM
;
Jin Hwa LEE
;
Yong Bum PARK
;
Eun Hee CHUNG
;
Yae-Jean KIM
;
Kwang Ha YOO
;
Yeon-Mok OH
Author Information
- Publication Type:Original Article
- From:Tuberculosis and Respiratory Diseases 2022;85(1):56-66
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Because the etiologies of bronchiectasis and related diseases vary significantly among different regions and ethnicities, this study aimed to develop a diagnostic bundle for bronchiectasis in South Korea.
Methods:A modified Delphi method was used to develop expert consensus statements on a diagnostic bundle for bronchiectasis in South Korea. Initial statements proposed by a core panel, based on international bronchiectasis guidelines, were discussed in an online meeting and two email surveys by a panel of experts (≥70% agreement).
Results:The study involved 21 expert participants, and 30 statements regarding a diagnostic bundle for bronchiectasis were classified as recommended, conditional, or not recommended. The consensus statements of the expert panel were as follows: A standardized diagnostic bundle is useful in clinical practice; diagnostic tests for specific diseases, including immunodeficiency and allergic bronchopulmonary aspergillosis, are necessary when clinically suspected; initial diagnostic tests, including sputum microbiology and spirometry, are essential in all patients with bronchiectasis, and patients suspected with rare causes such as primary ciliary dyskinesia should be referred to specialized centers.
Conclusion:Based on this Delphi survey, expert consensus statements were generated including specific diagnostic, laboratory, microbiological, and pulmonary function tests required to manage patients with bronchiectasis in South Korea.
